Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Daré Bioscience secures $6.0 million through a registered direct offering and concurrent private placement, led by institutional investors, to advance women's health solutions.

PRIVATEAug 14, 2026•1 day ago

Amount Raised

$6 Million

Round Type

Post-IPO Equity

San DiegoBiotechnology Research

Description

Daré Bioscience, Inc. announced a definitive securities purchase agreement with institutional investors for a registered direct offering of $6.0 million. The offering involves the sale of over 4.3 million shares at $1.37 each. Concurrently, the company will issue Series A and Series B warrants to purchase more shares

Company Information

Company

Daré Bioscience, Inc.

Location

San Diego, California, United States

About

Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women.

Don't miss Daré Bioscience, Inc.'s next move

Get an email the moment Daré Bioscience, Inc. raises, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Daré Bioscience, Inc.'s next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.